Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyl-5-FU prodrugs

被引:24
|
作者
Beall, HD
Sloan, KB
机构
[1] Univ Florida, Dept Med Chem, Gainesville, FL 32610 USA
[2] Univ Montana, Dept Pharmaceut Sci, Missoula, MT 59812 USA
关键词
3-alkylcarbonyl-5-fluorouracil; S-AQ; S-IPM; K-IPM : AQ; transformed Potts-Guy equation; diffusion cell experiments;
D O I
10.1016/S0378-5173(01)00609-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The solubilities in isopropyl myristate (S-IPM) and pH 4.0 buffer (S-AQ) and the partition coefficients between IPM and pH 4.0 buffer (K-IPM:AQ) have been measured for a series of 3-alkylcarbonyl-5-fluorouracil prodrugs (3-AC-5-FU). The 3-AC-5-FU prodrugs were all 100 times more soluble in IPM and the first two members of the series were also more soluble in pH 4.0 buffer than 5-FU. The abilities of the 3-AC-5-FU prodrugs to deliver total 5-FU species through hairless mouse skin from IPM suspensions (J(i)) were also measured. The 3-propionyl derivative 3, which exhibited the highest S-AQ in the series, gave the highest J(i) value. The S-IPM, S-AQ and molecular weights (mw) of the 3-AC-5-FU series correctly predicted the rank order and very closely (0.10 log units) predicted the absolute values for log J(i) using the transformed Potts-Guy equation. Although the series of 3-AC-5-FU prodrugs was generally quite effective at increasing J(i) (2-20 times), the best 3-AC-5-FU prodrug was not as effective as the best 1-alkylcarbonyl-5-FU prodrug (1-AC-5-FU) at increasing J(i) and the ability of the 3-AC-5-FU prodrugs to increase the concentration of total 5-FU species in the skin was 2-5 times less than the 1-AC-5-FU prodrugs. Thus, the 1-AC-5-FU prodrugs remain as the best prodrugs with which to enhance the topical delivery of 5-FU. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:127 / 137
页数:11
相关论文
共 50 条
  • [41] Effect of 5-fluorouracil (5-FU) infusion in myocardial perfusion scans
    Bishiniotis, T
    Mouratidou, D
    Pentheroudakis, G
    Andreadis, C
    Katseas, G
    Litos, A
    Hatseras, D
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 60 - 60
  • [42] Inhibition of lens epithelial growth using 5-fluorouracil (5-FU)
    McCauley, MB
    Scribbick, FW
    Reitstetter, RE
    Chapa, I
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2005, 46
  • [43] SYNERGISTIC LETHAL EFFECTS OF ENDOTOXIN AND 5-FLUOROURACIL (5-FU) IN MOUSE
    NOVAK, D
    DRUMMOND, D
    MUNSON, AE
    [J]. JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY, 1973, 13 (04): : 354 - 354
  • [44] EFFECTS OF 5-FLUOROURACIL (5-FU) OINTMENT IN TREATMENT OF NEOPLASTIC DERMATOSES
    KLEIN, E
    STOLL, HL
    MILLER, E
    MILGROM, H
    HELM, F
    BURGESS, G
    [J]. DERMATOLOGICA, 1970, 140 : 21 - +
  • [45] 5-FLUOROURACIL (5-FU) IN PRIMARY TRABECULECTOMY - A PROSPECTIVE, RANDOMIZED STUDY
    GOLDENFELD, M
    WONG, P
    RUDERMAN, J
    ROSENBERG, L
    KRUPIN, T
    GEISER, D
    LIEBMANN, J
    RITCH, R
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 815 - 815
  • [46] TREATMENT OF KERATOACANTHOMAS BY LOCAL APPLICATIONS OF 5-FLUOROURACIL (5-FU) OINTMENT
    GRUPPER, C
    [J]. DERMATOLOGICA, 1970, 140 : 127 - &
  • [47] ORAL 5-FLUOROURACIL (5-FU) AS AN ADJUVANT TO SURGERY IN CARCINOMA OF COLON
    HARVEY, H
    BADDER, E
    DEMUTH, W
    NAHRWOLD, D
    PATTERSON, L
    RICCI, J
    SHAVER, W
    WHITE, D
    LIPTON, A
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 314 - 314
  • [48] NEEDLING WITH 5-FLUOROURACIL (5-FU) AND BETAMETHASONE IN FAILING FILTERING BLEBS
    FERRARI, E
    LANZETTA, P
    VIRGIL, G
    MENCHINI, U
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S85 - S85
  • [49] TREATMENT OF BASAL CELL CARCINOMA WITH 5-FLUOROURACIL (5-FU) OINTMENT
    REYMANN, F
    [J]. DERMATOLOGICA, 1970, 140 : 34 - &
  • [50] 5-FLUOROURACIL (5-FU) OINTMENT IN TREATMENT OF SKIN TUMOURS AND KERATOSES
    ALMEIDAG.JC
    NORONHA, TD
    [J]. DERMATOLOGICA, 1970, 140 : 97 - &